Corticosteroid injection of the sacroiliac joint in patients with seronegative spondylarthropathy.
Maugars. Y Y; Mathis. C C; Vilon. P P; Prost. A A
Key Findings
- 79% of procedures were rated very good or good
- Improvement lasted on average about 10 months
- The injection technique was reported as safe and easy to perform
Practical Outcomes
- For the biohacker community this research isn’t actionable – it deals with a disease‑specific steroid injection, not a peptide or a protocol that can be applied to general health, metabolic or performance goals.
Summary
The study looked at giving corticosteroid shots into the sacroiliac joint of people with a specific arthritis (seronegative spondylarthropathy) and found most patients felt better for several months, but this has little relevance for peptide‑focused biohackers interested in general longevity or performance.
Abstract
We report our experience with the use of corticosteroid injections into the sacroiliac joint in the treatment of patients with seronegative spondylarthropathy. We performed 42 injections, constituting 24 procedures in 22 patients (2 patients had the procedure performed twice). The response was considered very good or good in 19 of 24 procedures (79.2%) and 34 of 42 joints (81%). Improvement persisted in 14 patients after a mean +/- SD followup time of 9.6 +/- 4.2 months. This technique appears to be safe, easy to apply into ambulatory patients, and quite effective.
Study Information
pubmed
1992
10.1002/art.1780350512